[Improved product characteristics of nicotine gums: an unexplored area for higher compliance with nicotine replacement therapy].

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

To assess consumer acceptance of new flavoured nicotine gums in comparison with existing nicotinegums.

Who Took Part

By PubMed's age tags, the people studied were teenagers, young adults, adults and middle-aged adults, both men and women.

A total of 607 adult smokers who intended to cut down or give up smoking were included in two randomised, single-blind, central location, acceptance tests.

A new fruit-flavoured nicotine gum (Gum A = Nicorette Freshfruit) was compared with an existing fruit-flavoured nicotine gum (Gum B = Nicotinell fruit), and a new menthol-flavoured gum (Gum N = Nicorette Icy White) was compared with two existing mint-flavoured gums (Gum M = Nicotinell mint; Gum Q = NiQuitin mint).

How the Study Was Run

The design is described as randomized and single-blind.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

In this single-blind Therapeutic nicotine (patch, non-peptide) study one party knew the assignments and the other did not.

What Was Measured

PubMed files the paper under topics including Consumer Behavior, Flavoring Agents, Medication Adherence, Nicotine, Smell, Taste and Tobacco Use Cessation Devices.

What This Means in Plain Language

The paper is a randomized and single-blind study of Therapeutic nicotine (patch, non-peptide).

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2011 (MMW Fortschritte der Medizin), a journal based in Germany.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.